Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs193922525
rs193922525
CFTR
A 0.840 CausalMutation CLINVAR

dbSNP: rs193922525
rs193922525
CFTR
A 0.840 GeneticVariation CLINVAR Search for mutations in pancreatic sufficient cystic fibrosis Italian patients: detection of 90% of molecular defects and identification of three novel mutations. 7544319

1995
dbSNP: rs193922525
rs193922525
CFTR
A 0.840 GeneticVariation CLINVAR Effects of cystic fibrosis and congenital bilateral absence of the vas deferens-associated mutations on cystic fibrosis transmembrane conductance regulator-mediated regulation of separate channels. 10762539

2000
dbSNP: rs193922525
rs193922525
CFTR
0.840 GeneticVariation UNIPROT Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. 11280952

2001
dbSNP: rs193922525
rs193922525
CFTR
0.840 GeneticVariation UNIPROT Standards and guidelines for CFTR mutation testing. 12394352

2003
dbSNP: rs193922525
rs193922525
CFTR
0.840 GeneticVariation BEFREE The cystic fibrosis mutation G1349D within the signature motif LSHGH of NBD2 abolishes the activation of CFTR chloride channels by genistein. 15163550

2004
dbSNP: rs193922525
rs193922525
CFTR
A 0.840 GeneticVariation CLINVAR Comprehensive cystic fibrosis mutation epidemiology and haplotype characterization in a southern Italian population. 15638824

2005
dbSNP: rs193922525
rs193922525
CFTR
0.840 GeneticVariation UNIPROT Cystic fibrosis prenatal screening in genetic counseling practice: recommendations of the National Society of Genetic Counselors. 15789152

2005
dbSNP: rs193922525
rs193922525
CFTR
0.840 GeneticVariation BEFREE We conclude that G551D- and G1349D-CFTR have distinct pharmacological profiles and speculate that drug therapy for CF is likely to be mutation-specific. 16311240

2006
dbSNP: rs193922525
rs193922525
CFTR
0.840 GeneticVariation UNIPROT Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health. 17761616

2007
dbSNP: rs193922525
rs193922525
CFTR
0.840 GeneticVariation UNIPROT ACOG Committee Opinion No. 442: Preconception and prenatal carrier screening for genetic diseases in individuals of Eastern European Jewish descent. 19888064

2009
dbSNP: rs193922525
rs193922525
CFTR
0.840 GeneticVariation UNIPROT Cystic Fibrosis Foundation practice guidelines for the management of infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome during the first two years of life and beyond. 19914443

2009
dbSNP: rs193922525
rs193922525
CFTR
0.840 GeneticVariation UNIPROT Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis. 19914445

2009
dbSNP: rs193922525
rs193922525
CFTR
0.840 GeneticVariation UNIPROT Guidelines on the early management of infants diagnosed with cystic fibrosis following newborn screening. 20605539

2010
dbSNP: rs193922525
rs193922525
CFTR
0.840 GeneticVariation UNIPROT Cystic fibrosis pulmonary guidelines: pulmonary complications: hemoptysis and pneumothorax. 20675678

2010
dbSNP: rs193922525
rs193922525
CFTR
0.840 GeneticVariation UNIPROT ACOG Committee Opinion No. 486: Update on carrier screening for cystic fibrosis. 21422883

2011
dbSNP: rs193922525
rs193922525
CFTR
A 0.840 GeneticVariation CLINVAR Genotype-phenotype correlation in cystic fibrosis patients bearing [H939R;H949L] allele. 21931512

2011
dbSNP: rs193922525
rs193922525
CFTR
0.840 GeneticVariation UNIPROT Good laboratory practices for biochemical genetic testing and newborn screening for inherited metabolic disorders. 22475884

2012
dbSNP: rs193922525
rs193922525
CFTR
0.840 GeneticVariation UNIPROT Molecular testing for cystic fibrosis carrier status practice guidelines: recommendations of the National Society of Genetic Counselors. 24014130

2014
dbSNP: rs193922525
rs193922525
CFTR
0.840 GeneticVariation UNIPROT Human Genetics Society of Australasia position statement: population-based carrier screening for cystic fibrosis. 25431289

2014
dbSNP: rs193922525
rs193922525
CFTR
0.840 GeneticVariation UNIPROT Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR. 25981758

2015
dbSNP: rs193922525
rs193922525
CFTR
0.840 GeneticVariation BEFREE However, mutations that disrupt the interaction of ATP with ATP-binding site 1, including K464A, D572N and the CF-associated mutation G1349D all abolished the prolongation of τ<sub>cf</sub> at pH<sub>i</sub> 6.3. 27779763

2017
dbSNP: rs193922525
rs193922525
CFTR
0.840 GeneticVariation BEFREE We have used this stabilized background to study the effects of NBD2 mutations identified in cystic fibrosis (CF) patients, demonstrating that mutants such as N1303K and G1349D are characterized by lower stability, as shown previously for some NBD1 mutations, suggesting a potential role for NBD2 instability in the pathology of CF. 28655774

2017